IP Library Granted Patent US 10,335,224
Granted Patent B2
US 10,335,224 · App. 14/851,508 · Granted Jul 2, 2019

Method of destroying tissue cells by electroporation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,335,224
App. No.
14/851,508
Granted
Jul 2, 2019
Kind
B2
Abstract

An apparatus and method for performing non-invasive treatment of the human face and body by electroporation in lieu of cosmetic surgery is provided. The apparatus comprises a high voltage pulse generator and an applicator having two or more electrodes in close mechanical and electrical contact with the patient's skin for applying the pulses to the patient's skin. The applicator may consist of two pieces with one electrode having a sharp tip and another having a flat surface. High voltage pulses delivered to the electrodes create at the tip of the sharp electrode an electric field high enough to cause death of relatively large subcutaneous fat cells by electroporation. Moving the electrode tip along the skin creates a line of necrotic subcutaneous fat cells, which later are metabolized by the body. Multiple applications of the electrode along predetermined lines on the face or neck create shrinkage of the skin and the subcutaneous fat volume underlying the treated area.

Claims (10)

1. A method of treating a living human body by destroying tissue cells, comprising:

positioning one or more electrodes over skin cells of the living human body, the skin cells of the living human body overlying fat cells of the living human body, the one or more positioned electrodes defining a target area containing fat cells to be killed in the living human body; and

treating the living human body by applying electrical pulses through the one or more positioned electrodes in an amount above an upper limit of electroporation to irreversibly open pores in membranes of the fat cells in the target area, thereby killing the fat cells in the target area.

2. The method of claim 1 , wherein the step of treating includes applying electrical pulses through the skin cells in an amount below an upper limit of electroporation for the skin cells, thereby selectively killing the fat cells in the target area.

3. The method according to claim 1 , wherein the step of positioning one or more electrodes includes positioning at least one flat electrode over the surface of the skin cells.

4. The method according to claim 1 , wherein the step of positioning one or more electrodes includes engaging at least one flat electrode over the surface of the skin cells and then positioning at least one needle-like electrode near the fat cells.

5. The method according to claim 1 , wherein the step of positioning the one or more electrodes includes positioning an array of electrodes over the skin cells of the living human body defining the target area.

6. The method according to claim 1 , wherein the step of positioning includes positioning an array of fixedly spaced apart electrodes near the target area.

7. The method according to claim 1 , wherein the step of applying includes applying electrical pulses each having a duration in a range of 10 microseconds and 100 milliseconds.

8. The method according to claim 1 , wherein the step of applying includes applying electrical pulses whose amplitude is in a range of 20 Volt/mm and 2000 Volt/mm and whose duration for each pulse is in a range of 10 microseconds and 100 milliseconds.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2022
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 061363/0446 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Jun 5, 2019
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 049371/0657 →
SECURITY INTEREST Recorded Nov 8, 2016
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 040613/0049 →